Table 3.
Association between log-transformed serum BFRs and prevalence of COPD stratified by gender.
| Subgroup | OR (95%CI) | P-value | P for interaction | |
|---|---|---|---|---|
| PBDE28 | Male | 2.15 (1.58, 2.92) | <0.0001 | <0.05 |
| Female | 1.01 (0.72, 1.41) | 0.95 | ||
| PBDE47 | Male | 2.08(1.62, 2.68) | <0.0001 | <0.05 |
| Female | 0.95 (0.69, 1.31) | 0.77 | ||
| PBDE85 | Male | 1.81 (1.44, 2.27) | <0.0001 | <0.05 |
| Female | 0.93 (0.70, 1.24) | 0.62 | ||
| PBDE99 | Male | 1.73 (1.41, 2.13) | <0.0001 | <0.05 |
| Female | 0.92 (0.70, 1.21) | 0.56 | ||
| PBDE100 | Male | 1.98 (1.56, 2.53) | <0.0001 | <0.05 |
| Female | 0.88 (0.65, 1.20) | 0.42 | ||
| PBDE154 | Male | 1.79 (1.44, 2.21) | <0.0001 | <0.05 |
| Female | 0.86 (0.64, 1.16) | 0.31 | ||
| PBDE183 | Male | 1.59 (1.27, 2.01) | <0.001 | 0.09 |
| Female | 1.04 (0.70, 1.53) | 0.86 | ||
| PBDE209 | Male | 1.32 (1.05, 1.66) | 0.02 | 0.10 |
| Female | 0.94 (0.68, 1.31) | 0.73 | ||
| PBB153 | Male | 1.15 (0.90, 1.48) | 0.27 | 0.59 |
| Female | 1.39 (1.03, 1.87) | 0.03 |